L. Shen, D. Sun / Tetrahedron Letters 52 (2011) 4570–4574
4573
O
O
CHO
CHO
b
c
e
d
BnO
RO
a
BnO
HO
OMe
14
OMe
12
16
OMe
OMe
15
R = H
O
13
R = Bn
O
O
g
f
R'O
O
HO
OMe
HO
OMe
18
R'O
19
pterocarine (2) R' = H
OMe
Br
17
OMe
Br
R' = Me
h
O
O
O
OMe
OMe
Br
i
k
j
8
R'O
l
O
MeO
Br
MeO
R'O
21
OH
OH
20
22
R' = Me
3 R' = H
Scheme 3. Synthesis of pterocarine (2) and regioisomer 3. Reagents and conditions: (a) PhCH2Br, K2CO3, MeOH, reflux, 4 h, 100%; (b) CH3CHO, 10% NaOH, EtOH, rt, 3 h, 20%;
(c) acetone, 10% NaOH, rt, overnight, 81%; (d) 10% Pd/C, H2, MeOH, rt, 2 h, 92%; (e) 3-Br-4-MeOC6H3CHO, 10% NaOH, EtOH, rt, 9.5 h, 52%; (f) 5% Pd/C, H2, Ph2S (0.05 equiv),
CHCl3, 18 h, 78%; (g) CuO, K2CO3, pyridine, 175 °C, 5 h, 54%; (h) AlCl3, CH2Cl2, reflux, 25 h, 62%; (i) 4-Br-3-MeOC6H3CHO, 10% NaOH, EtOH, rt, 3.5 h, 41%; (j) 5% Pd/C, H2, Ph2S
(0.05 equiv), 18 h, 80%; (k) CuO, K2CO3, pyridine, 175 °C, 5 h, 58%; (l) AlCl3, CH2Cl2, reflux, 11 h, 42%.
condensation reactions, and selective hydrogenations to generate
1,7-diphenylheptan-3-one variant 18, followed by the macrocyclic
Ullmann condensation and O-demethylation to afford pterocarine
(2). Accordingly, Claisen–Schmidt condensation of 8 with 4-bro-
mo-3-methoxybenzaldehyde followed by chemoselective reduc-
tion, macrocyclization, and demethylation gave the regioisomer 3.
Macrocyclic compounds 1–3 were fully characterized by mass
spectrometry, 1H and 13C NMR, and 2D HSQC, HMBC, and COSY
spectroscopy (See Supplementary data). Their complete 1H and
13C NMR spectra are shown in Figure 2a–f. The spectroscopic data
of our synthetic pterocarine (2) were identical with those of the
originally reported engelhardione1 as well as natural and synthetic
pterocarine.9,21 Moreover, on the basis of these spectra, interest-
ingly, we noted that minor structural changes in the substitution
patterns at the two aromatic rings result in dramatic differences
in their respective NMR spectra. Most notably, for meta and para
connected pterocarine (2) and regioisomer 3, high-field shifts of
and syntheses of their structural analogs are currently ongoing
and will be reported in due course.
Acknowledgments
We thank UH Hilo College of Pharmacy for the start-up funding,
and this work is also in part supported by INBRE program P20
RR016467 awarded by NCRR. We thank Dr. Philip Williams at Uni-
versity of Hawai0i at Manoa for performing high-resolution mass
spectrometric analysis of compound 11. We also thank Professor
Ih-Sheng Chen for providing NMR spectra of engelhardione.
Supplementary data
Supplementary data (experimental procedures for the synthesis
of compounds 1–22, copies of 1H and 13C NMR spectra, HPLC chro-
matographs for compounds 1–22, and HSQC, HMBC, and COSY
spectra of macrocyclic compounds 1–3, 11, 19, and 22) associated
with this article can be found, in the online version, at doi:10.1016/
H-20 (d = 5.59 ppm, d, J = 1.7 Hz) of
2
(Fig. 2b) and H-200
(d = 5.82 ppm, d, J = 2.0 Hz) of 3 (Fig. 2c) were observed due to
the anisotropic effect of the adjacent aromatic rings, as previously
reported.6,7,10 In contrast, the resonances of these aromatic protons
H-20 and H-200 from the meta–meta diaryl ether-linked 1 (Fig. 2a)
are at 6.51 and 6.45 ppm with a coupling constant value of
1.9 Hz, respectively. Differences of the chemical shifts of the ali-
phatic protons of the heptan-3-one chain among 1–3 were also ob-
served (Fig. 2a–c). Our data suggest that these macrocyclic
molecules display a high degree of conformational flexibility in
solution. Further evidence was demonstrated from the 1H NMR
data of 19, which was recorded in both non-polar CDCl3 and polar
DMSO-d6 for comparison. We noted that the signals of the geminal
protons in the heptyl chain of 19 merged together in DMSO-d6
compared to those signals recorded in CDCl3, additionally, changes
of chemical shifts from the aromatic protons were also observed
(See Supplementary data).
In conclusion, we report the first synthesis of engelhardione and
this effort led to the structural revision of this macrocyclic natural
product.22 The correct structure of the previously reported engel-
hardione should be that of pterocarine (2). To confirm, 2 and its
close regioisomer 3 were also synthesized. The published spectro-
scopic data of engelhardione were in full agreement with those of
pterocarine. Biological studies of these macrocyclic compounds
References and notes
1. Lin, W. Y.; Peng, C. F.; Tsai, I. L.; Chen, J. J.; Cheng, M. J.; Chen, I. S. Planta Med.
2005, 71, 171.
2. Keserü, G. M.; Nógrádi, M. In Studies in Natural Products Chemistry; Atta-Ur-
Rahman, Ed.; Elsevier Science, 1995; Vol. 17, p 357.
3. Ishida, J.; Kozuka, M.; Wang, H.-K.; Konoshima, T.; Tokuda, H.; Okuda, M.; Yang
Mou, X.; Nishino, H.; Sakurai, N.; Lee, K.-H.; Nagai, M. Cancer Lett. 2000, 159,
135.
4. Lee, K.-S.; Li, G.; Kim, S. H.; Lee, C.-S.; Woo, M.-H.; Lee, S.-H.; Jhang, Y.-D.; Son,
J.-K. J. Nat. Prod. 2002, 65, 1707.
5. Nomura, M.; Tokoroyama, T.; Kubota, T. Phytochemistry 1981, 20, 1097.
6. Gonzalez, G. I.; Zhu, J. J. Org. Chem. 1997, 62, 7544.
7. Gonzalez, G. I.; Zhu, J. J. Org. Chem. 1999, 64, 914.
8. Kishore Kumar, G. D.; Natarajan, A. Tetrahedron Lett. 2008, 49, 2103.
9. Wang, Q.; Son, J.-K.; Jahng, Y. Synth. Commun. 2007, 37, 675.
10. Jeong, B.-S.; Wang, Q.; Son, J.-K.; Jahng, Y. Eur. J. Org. Chem. 2007, 2007, 1338.
11. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Deliver. Rev.
2001, 46, 3.
12. Calculated using Advanced Chemistry Development (ACD/Labs) Software
V8.19 for Solaris (Ó 1994–2011 ACD/Labs).
13. Keserü, G. M.; Nógrádi, M.; Szöllösy, Á. Eur. J. Org. Chem. 1998, 1998, 521.
14. Evano, G.; Blanchard, N.; Toumi, M. Chem. Rev. 2008, 108, 3054.
15. When chloroform was initially used as solvent, the reaction was complete after
2.5 h. However, 19% of over-reduced secondary alcohol by-product was
produced based upon HPLC and 1H NMR monitoring. We found, when